Freeman, NJ
Brian Dean Freeman, Farmingdale, NJ US
Patent application number | Description | Published |
---|---|---|
20150095704 | PROCESSING DIAGNOSTICS OF MEDIA SERVICES - A system that incorporates the subject disclosure may include, for example, a device receiving diagnostic information from a plurality of client devices delivering media content, wherein the diagnostic information relates to a media delivery service quality and wherein the diagnostic information is sent automatically by the client devices; performing a data compression procedure for the diagnostic information; transmitting compressed data comprising the diagnostic information to an aggregator device; and sending to the client devices a message to delay or prevent transmission of additional diagnostic information in accordance with an instruction received from the aggregator device. Other embodiments are disclosed. | 04-02-2015 |
20160062746 | Software Defined Network Controller - Concepts and technologies are disclosed herein for providing and using a software defined network controller. A software defined network controller can be provided by a computing system that includes a processor. A service model that represents a service can be obtained. A network model that represents network resources that support the service can be obtained. Resources that support the service can be determined. Templates can be accessed to identify templates that relate to the resources. The templates identified can be assembled to obtain a template-based representation of the service. The template-based representation can be executed to determine if the service is ready for deployment. | 03-03-2016 |
20160080214 | PROCESSING DIAGNOSTICS OF MEDIA SERVICES - A system that incorporates the subject disclosure may include, for example, a device receiving diagnostic information from a plurality of client devices delivering media content, wherein the diagnostic information relates to a media delivery service quality and wherein the diagnostic information is sent automatically by the client devices; performing a data compression procedure for the diagnostic information; transmitting compressed data comprising the diagnostic information to an aggregator device; and sending to the client devices a message to delay or prevent transmission of additional diagnostic information in accordance with an instruction received from the aggregator device. Other embodiments are disclosed. | 03-17-2016 |
Daniel J. Freeman, Holmdel, NJ US
Patent application number | Description | Published |
---|---|---|
20150147326 | PROTEIN BIOMARKER AND USES THEREOF - The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at a protein level is assessed as high. The present invention is also directed to methods of identifying a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and withholding a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at a protein level is assessed as low. The invention is also directed to methods of performing an ELISA, including sequential steps of contacting a solid surface with a plurality of solutions each comprising in turn a capture antibody, a blocking agent, a sample suspected of containing an analyte, a detection antibody and an enzyme conjugate, in which the solid surface is subjected to a wash process after each sequential step. | 05-28-2015 |
20150152508 | NUCLEIC ACID BIOMARKER AND USE THEREOF - The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as high. The present invention is also directed to methods of identifying a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and withholding a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as low. | 06-04-2015 |
James J. Freeman, Hopewell, NJ US
Patent application number | Description | Published |
---|---|---|
20140262958 | PRODUCTION OF NON-CARCINOGENIC BRIGHTSTOCK EXTRACTS - Provided are multiple correlations for relationships between MI value for a brightstock extract and the distillation cut point temperature used for separation of the vacuum resid that is used to form the brightstock extract. Based on these correlations, a BSE having a desired MI value can be formed based on an adjustment of the distillation cut point temperature. A first correlation establishes a relationship between a fractional weight boiling temperature for a vacuum resid fraction and a distillation cut point temperature for separating the vacuum resid fraction from at least one distillate fraction in a feedstock. A second correlation establishes a relationship between a fractional weight boiling temperature for a brightstock extract derived from the vacuum resid fraction, and the fractional weight boiling temperature for the vacuum resid fraction. A third correlation has been established between the fractional weight boiling temperature for the brightstock extract and a mutagenicity index value. | 09-18-2014 |
John W. Freeman, East Orange, NJ US
Patent application number | Description | Published |
---|---|---|
20160051780 | Automatic Patient Ventilator System and Method - Ventilator enables operator to enter into the microprocessor estimate of a patient's individual characteristic, such as weight, which the microprocessor uses to control delivered tidal volume and other parameters to match the patient. The operator can select one of several ventilator operational modes (intube, mask, CPR). Sensors input data to the microprocessor to maintain parameter optimizations and accuracy. Visual/audible alarms and tools activate when one or more parameters exceed or fail to exceed predetermined values for patient's weight. Manual over-ride is available. The ventilator has a quick start capability in which the operator turns on power, selects the automatic operating mode, enters patient's characteristic, selects control option starting automatic ventilation of proper volumes inhalation/exhalation periods, pressure, and oxy-air mixture. | 02-25-2016 |
Paul M. Freeman, Branchburg, NJ US
Patent application number | Description | Published |
---|---|---|
20150041363 | DISPLAYABLE SHIPPING CONTAINER - A container blank includes a front panel, a first-end panel, a back panel, a second-end panel, a plurality of first-side flaps, a plurality of second-side flaps, and a door. Each of the plurality of first-side flaps and each of the plurality of second-side flaps extend from a respective one of the front panel, the first-end panel, the back panel, and the second-end panel. The door includes a door-front portion formed in the front panel, a first-door-side portion formed in the first-side flap extending from the front panel and a second-door-side portion formed in the second-side flap extending from the front panel. The first-door-side portion and the second-door-side portion include a first crushed zone on an interior surface of the blank. The first-side flap extending from the front panel and the second-side flap extending from the front panel each include a second crushed zone on an exterior surface of the blank. | 02-12-2015 |